KPV

Lysine-Proline-Valine. Anti-inflammatory tripeptide derived from alpha-MSH. Potent NF-kB inhibitor. Used for gut inflammation (IBD), skin conditions, and systemic inflammation.

Overview

Peptide

Lysine-Proline-Valine. Anti-inflammatory tripeptide derived from alpha-MSH. Potent NF-kB inhibitor. Used for gut inflammation (IBD), skin conditions, and systemic inflammation.

Effects on Markers

May reduce inflammatory markers (CRP, IL-6, TNF-alpha) through NF-kB pathway inhibition. No significant direct impact on hormones, lipids, liver enzymes, or haematology. No melanotropic (tanning) effects despite alpha-MSH origin.

Compound Guide

Structure: C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). Retains anti-inflammatory activity without melanocortin receptor activation (no tanning effect).

Dosage:

  • Gut inflammation: 200-500mcg/day SubQ or oral
  • Standard titration: 200mcg/day (week 1) → 300mcg (week 2) → 400-500mcg (weeks 3-8)
  • Oral (gut-specific): 200-500mcg/day in capsule form

Administration:

  • SubQ injection for systemic anti-inflammatory effect
  • Oral for gut-targeted inflammation (IBD, colitis, leaky gut)
  • 27-30g insulin syringe for SubQ

Key Notes:

  • Potent inhibitor of NF-kB — the master inflammatory transcription factor
  • Reduces pro-inflammatory cytokines: TNF-alpha, IL-6, IL-1beta
  • Popular for inflammatory bowel conditions — can be taken orally for direct gut action
  • No melanocortin receptor activation — does not cause tanning, appetite changes, or libido effects
  • Often stacked with BPC-157 for gut healing (BPC-157 heals tissue, KPV reduces inflammation)
  • Very well tolerated — minimal systemic side effects
  • May help reduce elevated CRP in users with chronic inflammation
  • Reconstitute with bacteriostatic water, store refrigerated

Important caveat on route: every study showing an effect on gut inflammation used the oral or rectal route, because KPV is carried into inflamed gut tissue by the PepT1 transporter. No study has tested subcutaneous KPV for any inflammatory outcome. Full evidence review: Does KPV peptide actually calm inflammation in the gut?.

Usage History

Markers to Monitor

Pairs With

How KPV behaves when it is run alongside other compounds.

Commonly stacked with

Used to offset

Stacks the risk

Frequently Asked Questions

Quick Reference

Category

Peptide

Half-Life

Unknown

Detection Time

N/A

Usage Summary